These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1396989)

  • 1. Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aorta.
    Fujimoto M; Mihara S; Shigeri Y; Itazaki K
    Eur J Pharmacol; 1992 May; 215(2-3):259-64. PubMed ID: 1396989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT1 receptor characteristics of angiotensin analogue binding in human synovium.
    Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J
    Br J Pharmacol; 1994 Jun; 112(2):435-42. PubMed ID: 8075862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human aortic smooth muscle cells containing angiotensin II type 1 receptors.
    Yazawa H; Iida-Kubota E; Honda K
    Jpn J Pharmacol; 1993 Aug; 62(4):339-43. PubMed ID: 8230860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidases and smooth muscle cell angiotensin II receptor pharmacology.
    Cohen RB; Webb ML; Dickinson KE
    Peptides; 1993; 14(2):345-52. PubMed ID: 8483812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH; Sullivan MJ; Wright JW; Harding JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat.
    Harding JW; Yoshida MS; Dilts RP; Woods TM; Wright JW
    J Neurochem; 1986 Apr; 46(4):1292-7. PubMed ID: 3950629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of selective, high affinity [125I]-angiotensin and [125I]-bradykinin binding sites in rat intestinal epithelia.
    Cox HM; Munday KA; Poat JA
    Br J Pharmacol; 1986 Jan; 87(1):201-9. PubMed ID: 2869810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
    Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
    Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of renal angiotensin II receptors using subtype selective antagonists.
    Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptors labelled with 125I-[Sar1, Ile8]-AII in albino rabbit ocular tissues.
    Mallorga P; Babilon RW; Sugrue MF
    Curr Eye Res; 1989 Aug; 8(8):841-9. PubMed ID: 2791629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist.
    Hong KW; Kim CD; Lee SH; Yoo SE
    Fundam Clin Pharmacol; 1998; 12(1):64-9. PubMed ID: 9523186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II binding activity in cultured porcine arterial endothelial cells.
    Mineo C; Shimizu H; Takada K; Imanaka T; Takano T
    Biochem Pharmacol; 1994 Nov; 48(10):1993-5. PubMed ID: 7986215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats.
    Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE
    Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist.
    Noda M; Shibouta Y; Inada Y; Ojima M; Wada T; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    Biochem Pharmacol; 1993 Jul; 46(2):311-8. PubMed ID: 8347154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.